Helios cereblon E3 ligase modulator (Bristol Myers Squibb)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHelios cereblon E3 ligase modulator (Bristol Myers Squibb)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUbiquitin-protein ligases modulatorsCereblon modulators
TargetsUbiquitin-protein ligasesCereblon
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A